How should insurers price pandemic risk in long term liability portfolios?

Long-term liability books such as pensions and life insurance are vulnerable to pandemics because these events create simultaneous, cross-sector losses and long-lasting shifts in mortality, morbidity, and economic conditions. Christian Gollier, Toulouse School of Economics, has emphasized that pandemics are low-frequency, high-severity events with deep uncertainty about probabilities and socioeconomic responses. Swiss Re Institute highlights the systemic correlation across lines and jurisdictions that makes diversification hard and capital planning more complex.

Pricing challenges

Insurers face severe model risk when estimating pandemic exposures. Historical samples are sparse, public policy responses are endogenous, and behavioral changes can alter claim patterns in ways that standard actuarial models miss. This produces uncertainty around tail dependence and persistence that must be reflected in price. Regulators and markets also react: capital and liquidity requirements rise after shocks, driving capital charges and affecting long-term pricing and product design. Cultural and territorial differences in health systems, reporting, and social behaviors mean identical products can have very different risk profiles across countries, creating heterogeneous underwriting outcomes.

Modeling, transfer and governance

Practical approaches combine conservative statistical techniques with institutional solutions. Scenario-based stress testing and reverse stress tests that incorporate extreme but plausible policy responses and secondary effects should be standard. Multi-scenario stress testing and forward-looking capital add transparency to reserves and pricing. Market transfers such as reinsurance, catastrophe bonds, and pandemic-linked securities can shift tail risk to capital markets, but design must manage basis risk and moral hazard. The World Bank’s past use of Pandemic Emergency Financing mechanisms illustrates both the strengths and limits of parametric transfers and the need for clear triggers and rapid payout mechanisms.

Public-private coordination is essential. Insurers should price with explicit loadings for uncertainty, maintain clear documentation of assumptions, and engage with health authorities and international institutions to align triggers and data sharing. Without these steps, firms risk underpricing systemic exposures, undermining solvency, or withdrawing coverage—outcomes that exacerbate social and territorial inequalities in protection. Combining conservative pricing, robust capital, and cooperative risk-sharing preserves market capacity while recognizing the unique nature of pandemic risk.